Results for this period
Third quarter1 January 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
In the Chemicals business, products added through the acquisition of a business, new business wins, sales growth in Southwest Asia, South Korea and the semiconductor market, efforts to substitute raw materials, and price revisions contributed to higher revenue and profit. The Cosmetics business reported lower revenue and profit due to rising prices, deteriorating market conditions, fewer repeat orders and strategically increased costs.
None
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 September 2026 |
| Net Sales | ¥47,281 million (YoY +14.7%) |
| Operating profit | ¥4,243 million (YoY +46.2%) |
| Ordinary income | ¥4,291 million (YoY +55.5%) |
| Profit attributable to owners of the parent | ¥3,084 million (YoY +91.2%) |
| Net income per share | ¥193.48 |
| Equity ratio | End of the current fiscal period 46.6 / End of previous period 47.5 |
| Total assets | ¥81,709 million |
| Net assets | ¥41,377 million |
| Full-year earnings forecast | Net Sales ¥64,000 million (YoY +14.9%) / Operating profit ¥5,400 million (YoY +40.4%) / Ordinary income ¥5,400 million (YoY +40.3%) / Net income ¥3,800 million (YoY +59.4%) |
| Revision to Earnings Forecast | No change |
| Annual Dividend Forecast | ¥60 → ¥70 |
| Segment revenue | Chemicals ¥35,953 million (YoY +22.0%), Cosmetics ¥10,765 million (YoY -5.1%), Other ¥563 million (YoY +41.7%) |
| Segment profit | Chemicals ¥4,857 million (YoY +63.0%), Cosmetics ¥951 million (YoY -33.5%), Other ¥2 million (YoY -95.3%) |
| Depreciation and amortization | ¥1,578 million |
| Impairment loss | ¥11 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥1 million, Gain on sale of investment securities ¥9 million, Insurance proceeds received ¥50 million, Gain on negative goodwill ¥7 million / Extraordinary loss Loss on disposal of non-current assets ¥3 million, Loss on sale of property, plant and equipment ¥0 million, Disaster Losses ¥57 million, Impairment loss ¥11 million |
| Disclosure regarding the going concern assumption | None |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | No material changes (no additions or exclusions of companies, or company names, were disclosed) |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 17,710,000 shares |
| Treasury Shares at Period-End | 1,669,757 treasury shares |
| Factors Behind Changes in Business Performance | In the Chemicals business, products added through the acquisition of a business, new business wins, sales growth in Southwest Asia, South Korea and the semiconductor market, efforts to substitute raw materials, and price revisions contributed to higher revenue and profit. The Cosmetics business reported lower revenue and profit due to rising prices, deteriorating market conditions, fewer repeat orders and strategically increased costs. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Chemicals business, the addition of products through the acquisition of a business, new business wins, and sales growth in Southwest Asia, South Korea and semiconductor-related markets, together with efforts to substitute raw materials and price revisions, contributed to higher revenue and profit. The Cosmetics business, however, reported lower revenue and profit due to rising prices, deteriorating market conditions, fewer repeat orders and strategically increased costs.